Archived Facts

(Reuters) – An experimental Merck & Co insomnia drug significantly reduced the time it took patients to fall asleep and helped them stay asleep longer, according to data from a pair of pivotal late-stage studies.

Popular Posts:

Related Posts:

Leave a Reply